News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Sanofi-Aventis (France) and Merck & Co., Inc. Begin Vet Drugs Sale
October 22, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, Oct 21 (Reuters) - Merck & Co Inc (MRK.N) and Sanofi-Aventis SA (SASY.PA) have begun selling parts of the businesses they are combining to form the world's largest animal-health operation, people familiar with the matter said.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
Merck & Co.
Sanofi
MORE ON THIS TOPIC
Manufacturing
Roche licensing pact clears generic drugmakers to manufacture antiviral flu drug
May 21, 2026
·
2 min read
·
Nick Paul Taylor
Artificial intelligence
Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling
May 21, 2026
·
3 min read
·
Tristan Manalac
Deals
Lilly and Engage Bio tie the knot with $202M acquisition
May 20, 2026
·
2 min read
·
Gabrielle Masson
Job Trends
Takeda cuts send layoffs soaring in May, rising year over year
May 19, 2026
·
4 min read
·
Angela Gabriel